Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor α levels and inhibiting adhesion of T lymphocytes to extracellular matrix
- 31 July 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (1) , 60-67
- https://doi.org/10.1016/s0168-8278(98)80179-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.Gut, 1996
- Immunotoxicology of host-response-mediated experimental liver injuryJournal of Hepatology, 1994
- Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-AspClinical and Experimental Immunology, 1994
- Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced miceBritish Journal of Surgery, 1993
- Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor β and interleukin 6Journal of Cellular Physiology, 1992
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortalityLife Sciences, 1989
- Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.The Journal of cell biology, 1989
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- PentoxifyllineDrugs, 1987